Dhanuka Agritech Limited has announced the acquisition of international rights for two crucial active ingredients, Iprovalicarb and Triadimenol, from Bayer AG, Germany. This strategic move aims to strengthen Dhanuka Agritech’s position in the agrochemical sector by diversifying its portfolio and expanding its global reach.
Key Highlights of the Acquisition:
- Ingredients Details:
- Iprovalicarb: Widely used for its effectiveness against crop diseases, particularly in viticulture and horticulture.
- Triadimenol: Known for its fungicidal properties, offering long-lasting protection for a variety of crops.
- Strategic Importance:
- Enhances Dhanuka Agritech’s product offerings in the fungicide segment.
- Enables the company to target global markets with proven agrochemical solutions.
- Market Impact:
- The acquisition is expected to open new revenue streams for Dhanuka Agritech by leveraging Bayer’s well-established ingredients.
- Strengthens the company’s research and development pipeline to develop innovative solutions for global agriculture.
Official Communication:
In a notification to the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE), Dhanuka Agritech shared details about the acquisition, highlighting its significance for future growth.
TOPICS:
Dhanuka Agritech